WebApr 6, 2024 · Diaceutics - DXRX Share Forecast, Price & News GBX 103.50 -4.00 (-3.72%) (As of 03/17/2024 12:00 AM ET) Compare Today's Range 103.50 107 50-Day Range 78.05 118 52-Week Range 1.05 122.22 Volume 37,850 shs Average Volume 73,951 shs Market Capitalization £87.43 million P/E Ratio 8,200.00 Dividend Yield N/A Price … WebSep 8, 2024 · Diaceutics’ advisory panel of global experts have more than 120 years of collective experience in Precision Medicine testing ... (ASCO) Annual Meeting, demonstrates from the data that there was ...
Diaceutics Secures $7 Million Subscription Data Services Contracts ...
WebApr 25, 2024 · Diaceutics PLC (the “Company” or the “Group”), a diagnostic commercialisation company for precision testing, is pleased to report its audited results … WebDec 31, 2024 · Peter Keeling, Diaceutics’ Chief Executive, commented: “We are delighted to report a strong year for Diaceutics, both financially and strategically, with revenues … image transfer pacs
Annual Diaceutics Report Illuminates State Of Diagnostic
WebOct 10, 2024 · Diaceutics' data capability is one of the three key value drivers it has integrated into its unique DXRX platform alongside its global lab network and product … WebDec 14, 2016 · The Diaceutics report includes a comprehensive review and update of 23 pharmaceutical and biotechnology companies with at least one diagnostically-enabled therapy on the market or significant pipeline investment in biomarkers, and ranks them according to their potential to capitalize on opportunities in diagnostic test-driven markets. WebMar 15, 2024 · 15 March, 2024. Diaceutics PLC (AIM: DXRX), a diagnostic commercialisation company for precision testing, reports its audited results for the year … image transfer technology providers